ホーム > 沖山奈緒子/ Okiyama, Naoko

沖山奈緒子

ALUMNI 2025年6月現在、筑波大学が主たる所属機関ではありません

Okiyama, Naoko

東京科学大学 , 大学院医歯学総合研究科　皮膚科学 , 教授
Institute of Science Tokyo , Department of Dermatology, Graduate School of Medical and Dental Sciences , Professor

http://dermatology-tsukuba.org/

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。

41. Dermatomyositis: Muscle Pathology According to Antibody Subtypes. Jantima Tanboon; Michio Inoue; Yoshihiko Saito; Hisateru Tachimori (+4 著者) Ichizo Nishino
Neurology 98: e739-e749 (2021) Semantic Scholar
42. Possible activation of effector B cells during drug-induced hypersensitivity syndrome Yutaka Matsumura; Rei Watanabe; Yasuko Niijima; Haruka Kawakita (+5 著者) Manabu Fujimoto
Journal of Cutaneous Immunology and Allergy 4: 166 (2021) Semantic Scholar
43. Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy. Yuri Okada; Rumiko Izumi; Tatsuhiko Hosaka; Satoshi Watanabe (+7 著者) Masashi Aoki
Rheumatology (Oxford, England) 61: e90-e92 (2021) Semantic Scholar
44. Successful treatment of pulmonary hypertension with immunosuppressive therapy in a case of anti-synthetase syndrome. Naoko Okiyama; Riko Iwasaki; Maki Fukuzono; Rumiko Endo (+5 著者) Toshifumi Nomura
The Journal of dermatology 48: e545-e546 (2021) Semantic Scholar
45. Case of anti‐nuclear matrix protein 2 antibody‐positive juvenile dermatomyositis preceded by linear cutaneous lupus erythematosus on the face Hanako Miyahara; Naoko Okiyama; Mari Okune; Risa Konishi (+5 著者) Toshifumi Nomura
The Journal of Dermatology 49: e18-e19 (2021) Semantic Scholar
46. A case of anti-PL-7 antibody-positive anti-synthetase syndrome with dermatomyositis-associated erythema induced sclerodermatous changes. Maki Fukuzono; Katsuhito Sasaki; Yuki Ichimura; Sae Inoue (+9 著者) Naoko Okiyama
Rheumatology (Oxford, England) 60: e362-e364 (2021) Semantic Scholar
47. Depletion of PD-1 or PD-L1 did not affect the mortality of mice infected with Mycobacterium avium. Masayuki Nakajima; Masashi Matsuyama; Mio Kawaguchi; Sosuke Matsumura (+10 著者) Nobuyuki Hizawa
Scientific reports 11: 18008 (2021) Semantic Scholar
48. Invasive Squamous Cell Carcinoma and Numerous Bowen Disease Lesions of the Hand and Foot With Infection of HPV-18 and HPV-45. Akemi Maeda; Yoshiyuki Nakamura; Shoichiro Ishizuki; Noriko Kubota (+4 著者) Yasuhiro Fujisawa
The American Journal of dermatopathology 43: 676 (2021) Semantic Scholar
49. Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis. Naoko Okiyama; Yuki Ichimura; Miwako Shobo; Ryota Tanaka (+9 著者) Manabu Fujimoto
Annals of the rheumatic diseases 80: 1201 (2021) Semantic Scholar
50. A prospective, phase II study on the safety and efficacy of negative pressure closure for the stabilization of split-thickness skin graft in large or muscle-exposing defects: The NPSG study. Yoshiyuki Nakamura; Yosuke Ishitsuka; Katsuhito Sasaki; Shoichiro Ishizuki (+5 著者) Yasuhiro Fujisawa
The Journal of dermatology 48: 1350 (2021) Semantic Scholar
51. Papulonodular lesions in Erdheim-Chester disease. Kazumasa Oya; Yosuke Ishitsuka; Yoshiyuki Nakamura; Rei Watanabe (+2 著者) Yasuhiro Fujisawa
The Journal of dermatology 48: e445-e446 (2021) Semantic Scholar
52. The relationship between anti-phosphatidylserine/prothrombin complex IgM antibodies and cutaneous ulcers in patients with cutaneous vasculitis. Tamihiro Kawakami; Naoko Okiyama; Masanari Kodera; Mariko SeishimaYukie Yamaguchi
The Journal of dermatology 48: 1457 (2021) Semantic Scholar
53. PD-1 Regulates Passive Anaphylaxis: A Possible Role of the Mast Cell Intracellular Inhibitory Signal. Tatsuya Ogawa; Yosuke Ishitsuka; Yoshiyuki Nakamura; Rei Watanabe (+2 著者) Manabu Fujimoto
Allergy, asthma & immunology research 13: 819 (2021) Semantic Scholar
54. Combination Treatment of Topical Imiquimod Plus Anti-PD-1 Antibody Exerts Significantly Potent Antitumor Effect. Kazumasa Oya; Yoshiyuki Nakamura; Zhu Zhenjie; Ryota Tanaka (+8 著者) Yasuhiro Fujisawa
Cancers 13: (2021) Semantic Scholar
55. Serum lactate dehydrogenase level as a possible predictor of treatment preference in psoriasis. Hanako Koguchi-Yoshioka; Rei Watanabe; Yutaka Matsumura; Yosuke Ishitsuka (+7 著者) Manabu Fujimoto
Journal of dermatological science 103: 109 (2021) Semantic Scholar
56. Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial Satoshi Ebata; Ayumi Yoshizaki; Koji Oba; Kosuke Kashiwabara (+10 著者) Shinichi Sato
The Lancet Rheumatology 3: e489 (2021) Semantic Scholar
57. Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash Yuki Ichimura; Risa Konishi; Miwako Shobo; Sae Inoue (+17 著者) Naoko Okiyama
Rheumatology 61: 1222 (2021) Semantic Scholar
58. Anti-NXP2 antibody-positive dermatomyositis with aortic thrombus in normal aortic wall. Nozomu Tawara; Satoshi Yamashita; Chikako Nagatoshi; Makoto Nakajima (+2 著者) Yukio Ando
Rheumatology (Oxford, England) 60: e159-e161 (2021) Semantic Scholar
59. Augmented interferon I signaling in a patient with COVID toes Kazuhiro Komura; Yuki Ichimura; Naoko Okiyama; Kazuyoshi Watanabe (+1 著者) Takashi Matsushita
Journal of Dermatology 48: e242 (2021) Semantic Scholar
60. 皮膚所見を欠いた抗nuclear matrix protein(NXP)-2抗体陽性皮膚筋炎の1例竹内恵里子; 廣澤太輔; 沖山奈緒子; 井上道雄 (+1 著者) 須貝文宣
Rinsho shinkeigaku = Clinical neurology 61: 258 (2021) Semantic Scholar

« 1 2 3 4 5 … 10 »

書籍等出版物情報はまだありません。

講演・口頭発表情報はまだありません。

1. 特願2023-030454: 特発性後天性全身性無汗症治療薬及び特発性後天性全身性無汗症病態モデルマウス
飯田忠恒; 並木剛; 井川奈緒子; 横関博雄

1,551 total views

この研究者の他の情報源

キーワードが似ている研究者

鍋倉宰 ALUMNI 免疫学, Immunology
中井啓嚥下障害, dysphagia
古田淳一 Dermatology, 皮膚科学
倉本尚美 ALUMNI Dysphagia, 嚥下障害
田原聡子 ALUMNI 免疫学, Immunology

この研究者の他の情報源

キーワードが似ている研究者

この研究者の情報を共有